6-Bromo-3-chloropicolinic acid, 95.0%, 1g

2-(DIFLUOROMETHYL)-6-FLUOROPYRIDINE, 95%, 100mg

(2-Bromo-5-methoxyphenyl)acetaldehyde, 97.0%, 1g

2-Bromoimidazo[2,1-b][1,3,4]thiadiazole, 95.0%, 10g

2-{2-[(tert-Butoxy)carbonyl]-2-azaspiro[3.3]heptan-6-yl}acetic acid, 97%, 100mg

2-(4-Methylpentyl)pyridine, 1g

2-feniletanolo, min 99%, per sintesi, 5 ml, confezione in vetro

2-Aminopent-4-enoic acid, 95.0%, 1g

(E)-N'-cyano(methylsulfanyl)methanimidamide, 95.0%, 1g

Methyl 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate>98.0%(HPLC)(T)5g

2,3-Dichlorotoluene>98.0%(GC)25g

2,5-Difluoropyridine, 98.00%, 1g

anti-cheratina K18 monoclonale di topo, Ks18.04, 0,2 ml